iApotek Int AB (publ) (XSAT:IAPO) entered into an agreement to acquire PharmArt AB from RinaPharm AB on March 16, 2018. Under the terms of the transaction, the initial consideration of SEK 9 million will be paid as 50% in cash and 50% in the form of shares of iApotek. Based on sales and EBITDA results, additional purchases, consisting of shares in iApotek, may also be paid. PharmArt reported revenue of SEK 10 million in 2017. The agreement is conditional on the implementation of a new issue.